Document Detail


Genome-wide screening of aberrant DNA methylation which associated with gene expression in mouse skin cancers.
MedLine Citation:
PMID:  24115114     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Epigenetic alteration of genomic DNA is a common and key process in carcinogenesis. There is considerable evidence indicating that some of the somatic alterations occurring during carcinogenesis in humans also involve the same processes as those observed in mice. Therefore, we analyzed mouse skin cancer tissues induced by the 2-stage carcinogenesis model to identify skin tumor-specific differentially methylated regions (ST-DMRs) during the multistep carcinogenesis process. We have previously identified ST-DMRs using the restriction landmark genomic scanning (RLGS) technique and reported that some of the mouse ST-DMRs were also epigenetically modified in human cancers, such as melanoma, neuroblastoma, and brain tumor. These results encouraged us to pursue global methylation screening in mouse skin carcinogenesis. Using the methylated DNA immunoprecipitation (MeDIP) method combined with the NimbleGen promoter plus CpG island (CpGi) array, we identified 615 ST-DMRs. In combination with global gene expression analysis, 91 of these ST-DMRs were shown to be located on or around the genes differentially expressed between normal skin and tumor tissues, including a candidate human tumor suppressor gene Tfap2e. As observed in human colorectal cancers, Tfap2e was methylated at a CpGi located in intron 3 and downregulated in skin tumors. Our results identified aberrant methylated regions that were associated with gene expression regulation during carcinogenesis, which may indicate critical genetic regions also involved in human carcinogenesis. © 2013 Wiley Periodicals, Inc.
Authors:
Kyoko Fujiwara; Srimoyee Ghosh; Ping Liang; Evan Morien; Masayoshi Soma; Hiroki Nagase
Related Documents :
22609284 - Why biosynthetic genes for chemical defense compounds cluster.
22768844 - A systems genetics approach identifies genes and pathways for type 2 diabetes in human ...
22358644 - Transfer and expression of the human multiple drug resistance gene as potential human g...
22537144 - Enhancer identification in mouse embryonic stem cells using integrative modeling of chr...
14500904 - Drosophila screening model for metastasis: semaphorin 5c is required for l(2)gl cancer ...
19470754 - Xrcc2 and xrcc3 regulate the balance between short- and long-tract gene conversions bet...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-9-24
Journal Detail:
Title:  Molecular carcinogenesis     Volume:  -     ISSN:  1098-2744     ISO Abbreviation:  Mol. Carcinog.     Publication Date:  2013 Sep 
Date Detail:
Created Date:  2013-10-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8811105     Medline TA:  Mol Carcinog     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 Wiley Periodicals, Inc.
Affiliation:
Innovative Therapy Research Group, Nihon University Research Institute of Medical Science, Nihon University School of Medicine, Tokyo, Japan; Division of General Medicine, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Central skull base osteomyelitis: An emerging clinical entity.
Next Document:  Long term functional and quality of life evaluation after treatment of advanced pharyngolaryngeal ca...